2014 04-25
Authors: Vargas KG, Tajsic M, Latsuzbaia A, Bastian S, Andric T, Kassem M, Jäger B, Huber K
Little is known about the role of gender in the dual biomarker strategy using copeptin and troponin for the early rule-out of non-ST-elevation myocardial infarction (NSTEMI). We aimed to evaluate gender-based differences on copeptin levels, combined negative predictive value (NPV) and predictors of copeptin elevation at admission.
The American Journal of Emergency Medicine